Seltek Consultants

Commerical Scientific Recruitment

Please be aware this account is not monitored, to get in touch, please see our website or find us on LinkedIn.

[Seltek Consultants @seltek]

The companies Upstream Bio, Alkeus Pharmaceuticals, Inc. and Worg Pharmaceuticals bagged the biggest biotech investments in June 2023, with #oncology and #ophthalmology players in particular attracting the most funding rounds. https://t.co/TPgAe4dxAa

[Seltek Consultants @seltek]

🎉Genomics England celebrates a decade of life-changing discoveries in genomics
#ourDNAdecade https://t.co/YErT3HXzFR

[Seltek Consultants @seltek]

PrecisionLife, a TechBio company driving precision medicine in complex chronic diseases, has announced a data access agreement with the University of Oxford to spearhead new treatments for #endometriosis. https://t.co/calUryic9w

[Seltek Consultants @seltek]

Researchers at Imperial College London in the U.K. have confirmed that the tumors of some women with high-grade serious ovarian cancer (HGSOC) contain a type of lymphoid tissue – known as tertiary lymphoid structures, or TLS – and…https://t.co/FmSzaP53qO https://t.co/iXKGL91U0Q

[Seltek Consultants @seltek]

I am sure many of us can share the pain that researchers at Rensselaer Polytechnic Institute must be feeling.

What reasons have caused you to lose samples/research in the past? https://t.co/wNeADi8AQA

[Seltek Consultants @seltek]

NodThera has shared positive results from its initial studies of NT-0249 and NT-0796, its lead therapeutic candidates. Both candidates demonstrated effective inhibition of the NLRP3 inflammasome, a validated target for inflammatory diseases. https://t.co/qNRZmCW0E2

[Seltek Consultants @seltek]

Danish biomarker company Nordic Bioscience A/S says its PRO-C3 biomarker assay has received a Letter of Support (LoS) from the U.S. Food and Drug Administration (FDA). https://t.co/CJvjCUd3hw

[Seltek Consultants @seltek]

📢Hiring: Applications Scientist - IR Spectroscopy - South East UK

We are excited to be working closely with an innovative manufacturer of analytical chemistry instruments that are sold globally and are now looking for an Applications Scientist to join t…https://t.co/G5ev6ZXZmt

[Seltek Consultants @seltek]

Interesting article that delves into the realm of rare chromosome disorders and explores the remarkable efforts being made by biotech companies to address these disorders head-on. https://t.co/faT0p4y2dE

[Seltek Consultants @seltek]

The consequences of the climate crisis, soil degradation, and its impact on food and water security seem dire. But, as ambitious as it may sound, synthetic biology companies could alleviate some of the environmental burdens that th…https://t.co/HS5cqbEDyQ https://t.co/tKVmlMYRlm

[Seltek Consultants @seltek]

The most common cause of dementia, Alzheimer’s disease, is a brain disorder that is characterized by cognitive decline which often manifests itself through memory loss, feelings of disorientation and difficulty making decisions. https://t.co/HqHYYz0b17

[Seltek Consultants @seltek]

Quell Therapeutics, a developer of engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, has entered into a collaboration, exclusive option, and license agreement with AstraZeneca…https://t.co/dx9z07fUJg https://t.co/oR3Cckfd9f

[Seltek Consultants @seltek]

An often overlooked but critical part of our healthcare system that deserves a lot more recognition. In the UK alone, healthcare laboratories are involved in over 70% of diagnoses in the NHS and handle hundreds of millions of patient samples yearly.

#…https://t.co/egA4qIUoPE

[Seltek Consultants @seltek]

Would you take part in a clinical trial?

Despite the 66% of the UK public saying they would be willing to participate, more than nine in 10 people living in the U.K. never have.

There is huge untapped potential for trial recruitment. https://t.co/OJEBvS0omp

[Seltek Consultants @seltek]

The ‘Life Sci for Growth’ package brings together 10 different policies and will see £650 million invested into UK Life Science.

💰£121 million to improve commercial clinical trials to bring new medicines to patients faster.

💰£…https://t.co/UQ2C8I86QO https://t.co/zBwlGYKiSs

[Seltek Consultants @seltek]

The NGS Library Preparation Automation Market is thriving, but what are the key factors driving this growth?

This report looks in-depth at how the market is doing and profiles some of the key players, including:

Agilent Technolo…https://t.co/OVWQegEsXb https://t.co/jBFxLmi21I

[Seltek Consultants @seltek]

Antibiotic resistance has been an arms race that we have slowly started losing, could AI help outpace bacterial evolution?

#antibioticresistance #AI https://t.co/qgS9EdTWMw

[Seltek Consultants @seltek]

Interesting results so far. With the majority seeing a freeze, but there are still plenty of companirs looking to grow.

Want to join one of these expanding companies? Drop me a message. https://t.co/6Ywp8Fko3r

[Seltek Consultants @seltek]

Researchers at the University of Gothenburg in Sweden, working with French colleagues, have successfully developed a method able to kill the aggressive brain tumor glioblastoma. By blocking certain functions in the cell with a dock…https://t.co/G99R2WWBcW https://t.co/xK8VlNNkqR

[Seltek Consultants @seltek]

AstraZeneca has agreed new licensing deal with Revvity —the new moniker for the life sciences and diagnostics departments of PerkinElmer, Inc. https://t.co/zoMCNeA3UZ